As MTHFD2, which is overexpressed in cancers, promotes growth and metastasis, targeting MTHFD2 by its inhibitor TH9619 shows potent activity in inhibiting AML xenograft growth in vivo [33]. Here, MTHFD2 is linked to cancer.